Your browser doesn't support javascript.
loading
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma.
Guo, Shushan; Xu, Zhijian; Feng, Qilin; Zhang, Hui; Yu, Dandan; Li, Bo; Hu, Ke; Gao, Xuejie; Zhang, Qikai; Yi, Hongfei; Wu, Xiaosong; Song, Dongliang; Zhu, Huabin; Cai, Haiyan; Peng, Yu; Zhu, Weiliang; Shi, Jumei.
Afiliação
  • Guo S; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Xu Z; State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Feng Q; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhang H; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Yu D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Li B; State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Hu K; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Gao X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Zhang Q; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Yi H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Wu X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Song D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Zhu H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Cai H; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
  • Peng Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
  • Zhu W; State Key Laboratory of Drug Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. Electronic address: wlzhu@simm.ac.cn.
  • Shi J; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. Electronic address: shijumei@tongji.edu.cn.
Arch Biochem Biophys ; 747: 109771, 2023 Oct 01.
Article em En | MEDLINE | ID: mdl-37776936
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Arch Biochem Biophys Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: Arch Biochem Biophys Ano de publicação: 2023 Tipo de documento: Article